Stage IVA Oropharyngeal Squamous Cell Carcinoma Active Not Recruiting Phase 1 Trials for Cetuximab (DB00002)

IndicationStatusPhase
DBCOND0039579 (Stage IVA Oropharyngeal Squamous Cell Carcinoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01935921Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreated Stage III-IVB Head and Neck CancerTreatment
NCT01254617Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck CancerTreatment